O Brien Wealth Partners LLC Reduces Holdings in LifeStance Health Group, Inc. (NASDAQ:LFST)

O Brien Wealth Partners LLC trimmed its holdings in shares of LifeStance Health Group, Inc. (NASDAQ:LFST) by 31.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 216,371 shares of the company’s stock after selling 100,000 shares during the period. LifeStance Health Group comprises approximately 0.3% of O Brien Wealth Partners LLC’s holdings, making the stock its 22nd biggest holding. O Brien Wealth Partners LLC’s holdings in LifeStance Health Group were worth $1,595,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the business. Blue Trust Inc. increased its stake in shares of LifeStance Health Group by 124.4% during the 4th quarter. Blue Trust Inc. now owns 3,828 shares of the company’s stock worth $27,000 after purchasing an additional 2,122 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of LifeStance Health Group by 31.4% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 24,105 shares of the company’s stock worth $169,000 after purchasing an additional 5,767 shares in the last quarter. The Manufacturers Life Insurance Company increased its stake in shares of LifeStance Health Group by 10.5% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 81,741 shares of the company’s stock worth $572,000 after purchasing an additional 7,798 shares in the last quarter. MetLife Investment Management LLC increased its stake in shares of LifeStance Health Group by 14.3% during the 3rd quarter. MetLife Investment Management LLC now owns 80,422 shares of the company’s stock worth $563,000 after purchasing an additional 10,084 shares in the last quarter. Finally, Townsquare Capital LLC purchased a new stake in LifeStance Health Group in the 3rd quarter worth approximately $73,000. 85.50% of the stock is owned by hedge funds and other institutional investors.

LifeStance Health Group Trading Down 0.9 %

Shares of LFST opened at $7.91 on Friday. The company’s fifty day moving average is $7.64 and its two-hundred day moving average is $7.00. LifeStance Health Group, Inc. has a fifty-two week low of $4.64 and a fifty-two week high of $9.20. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.19.

LifeStance Health Group (NASDAQ:LFST) last announced its quarterly earnings results on Thursday, November 7th. The company reported ($0.02) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.05. The company had revenue of $312.70 million for the quarter, compared to analyst estimates of $302.25 million. LifeStance Health Group had a negative net margin of 7.90% and a negative return on equity of 6.66%. LifeStance Health Group’s revenue for the quarter was up 18.9% on a year-over-year basis. During the same quarter last year, the business earned ($0.17) EPS. Equities analysts predict that LifeStance Health Group, Inc. will post -0.18 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms have commented on LFST. Barclays lifted their target price on shares of LifeStance Health Group from $6.00 to $7.00 and gave the stock an “underweight” rating in a research note on Monday, November 11th. The Goldman Sachs Group raised shares of LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 target price for the company in a research note on Monday, December 16th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $8.70.

Insider Buying and Selling at LifeStance Health Group

In related news, Director Robert Bessler sold 75,000 shares of LifeStance Health Group stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $7.54, for a total transaction of $565,500.00. Following the transaction, the director now owns 1,424,447 shares in the company, valued at approximately $10,740,330.38. The trade was a 5.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 6.60% of the stock is owned by company insiders.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.